TrialRespiratory research2015

Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate to severe persistent asthma.

Kai-Michael Beeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.